Why is Syncom Formul. falling/rising?

As of 02-Sep, Syncom Formulations (India) Ltd is currently priced at 17.00, reflecting an increase of 0.18 or 1.07%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 1.19% during this period. It has outperformed its sector by 1.14% today. However, despite these short-term gains, the stock is trading below its moving averages across various time frames, indicating potential long-term weakness. The company has reported positive results over the last five consecutive quarters, with net sales growing significantly, but it also faces challenges with poor long-term growth metrics, including a substantial decline in annual net sales and operating profit over the past five years. In the broader market context, Syncom Formulations has outperformed the Sensex in the short term, with a 1-week return of +0.35% compared to the Sensex's -0.78%. However, the stock has underperformed over longer periods, with a year-to-date decline of -15.00% against the Sensex's +2.58%. This underperformance, coupled with a lack of domestic mutual fund investment, suggests that investor sentiment may be cautious despite recent positive results. The stock's high valuation compared to peers and the significant drop in its price over the past year further contribute to a mixed outlook, indicating that while there are some positive short-term movements, the long-term prospects remain uncertain.